Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04902027
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)Looking for participantsNCT05886920
What this trial is testing

D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Who this might be right for
Advanced Solid Tumors With MAPK Pathway Mutations
D3 Bio (Wuxi) Co., Ltd 67
Early research (Phase 1)Study completedNCT01895491
What this trial is testing

Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer

Who this might be right for
Breast Cancer
Reyon Pharmaceutical Co., Ltd. 9
Early research (Phase 1)Study completedNCT01834742
What this trial is testing

Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

Who this might be right for
Colorectal Cancer
Norgine 161
Testing effectiveness (Phase 2)Study completedNCT02431559
What this trial is testing

Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Ludwig Institute for Cancer Research 53
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Early research (Phase 1)Ended earlyNCT04691375
What this trial is testing

PY314 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorGynecologic CancerBreast Cancer+6 more
Ikena Oncology 86
Testing effectiveness (Phase 2)Study completedNCT01266967
What this trial is testing

GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

Who this might be right for
Melanoma and Brain Metastases
GlaxoSmithKline 172
Testing effectiveness (Phase 2)Ended earlyNCT01313663
What this trial is testing

Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT00521404
What this trial is testing

Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 65
Early research (Phase 1)Study completedNCT02250157
What this trial is testing

A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumor
Athenex, Inc. 35
Early research (Phase 1)Study completedNCT02063230
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects

Who this might be right for
Solid Tumors
AstraZeneca 32
Early research (Phase 1)Study completedNCT02027961
What this trial is testing

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Who this might be right for
Melanoma
MedImmune LLC 68
Large-scale testing (Phase 3)Study completedNCT01464086
What this trial is testing

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)

Who this might be right for
Li Fraumeni Syndrome
Gustave Roussy, Cancer Campus, Grand Paris 107
Testing effectiveness (Phase 2)Enrolling By InvitationNCT04093570
What this trial is testing

Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes
Taiho Oncology, Inc. 332
Early research (Phase 1)Study completedNCT00051675
What this trial is testing

Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas

Who this might be right for
Adenocarcinoma
XOMA (US) LLC 30
Early research (Phase 1)Study completedNCT02392611
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Solid Tumors and Lymphomas
Gilead Sciences 33
Early research (Phase 1)Study completedNCT01371487
What this trial is testing

GSK1120212 Food-effect Study

Who this might be right for
Cancer
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Study completedNCT02297139
What this trial is testing

Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb 17
Early research (Phase 1)Ended earlyNCT01297530
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies

Who this might be right for
Neoplasms
Bayer 5
Next Page